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Abstract: The fundamental role that aldol chemistry adopts in 
various disciplines, such as stereoselective catalysis or the 
biosynthesis of aromatic polyketides, illustrates its exceptional 
versatility. On one hand, numerous aldol addition reactions 
reliably transfer the stereochemical information from catalysts 
into various valuable products; on the other, countless aromatic 
polyketide natural products are produced by an ingenious 
biosynthetic machinery based on arene-forming aldol 
condensations. With the aim of complementing aldol 
methodology that controls stereocenter configuration, we 
recently combined these two tenets by investigating small-
molecule catalyzed aldol condensation reactions that 
stereoselectively form diverse axially chiral compounds by 
construction of a new aromatic ring. 
Introduction 
Atropisomers, by definition separable stereoisomers that arise 
from the restricted rotation about a single bond, have become 
indispensable compounds in various areas of application.[1] They 
facilitate the synthesis of a wide range of valuable products as 
chiral ligands used in stereoselective catalysis or serve human 
medicine as therapeutics with a well-defined molecular shape, 
such as the antibiotic vancomycin.[2] However, compared to the 
variety of methods that control stereocenter configuration, many 
stereoselective methods to prepare the individual compound 
classes with one or more stereogenic axes remain to be 
developed. Currently, efforts to design catalytic methods were 
mostly devoted on the preparation of axially chiral biaryls by 
kinetic resolution,[3] desymmetrization,[4] cross-coupling,[5] 
[2+2+2]-cycloadditions[6] or the conversion of stereodynamic 
biaryls into configurationally stable atropisomers.[7] With novel 
catalyst-controlled methods to selectively prepare a variety of 
atropisomeric structures, the full potential of this burgeoning 
class of compounds can be unleashed for future applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Selected atropisomers used as ligands in stereoselective catalysis 
(BINOL, BINAP) and in human medicine (antibiotic vancomycin). 
Atropisomerization 
Most applications profit from atropisomeric scaffolds when 
they are well-behaved chiral motifs throughout the entire 
temperature range of operation. It is hence crucial at the outset, 
to assess the relevant bonds for their propensity to rotation. 
Usually, restricted rotation to provide configurationally stable 
atropisomers results from strong steric interactions of nearby 
groups. Hence when considering the rotational profile of the 
bonds in question, a minimum of two large barriers are required 
to hinder rotation in both directions. To ensure high 
configurational stability in the case of biaryls, typically three or 
four ortho-substituents are hence necessary to sufficiently 
prevent atropisomer interconversion. For comparison, the bond 
rotational profile of a di-ortho-substituted biaryl is characterized 
by just one large barrier, and thermal atropisomerization thus 
occurs within seconds to minutes at ambient temperature (101 
kJmol–1, Figure 2). A third ortho-substituent usually provides the 
required second rotational barrier to suitably restrict rotation over 
a broad temperature range. A fourth ortho-substituent finally 
leads to two simultaneous steric interactions in both directions, 
which define the rotational barriers leading to increased 
configurational stability.  
While the number of substituents provides a first estimate, the 
rate of thermal atropisomerization is additionally influenced by 
the substituents size and orientation, bond lengths, and, if 
applicable, solvents.[8] 
 
 
 
 
 
 
 
Figure 2. Rotational barriers of selected di-,tri- and tetra-ortho-substituted 
biaryls. 
Besides thermal atropisomerization, the stereochemical 
integrity of atropisomers is further affected by intra- and 
intermolecular reactivity. In particular molecules bearing groups 
which react with each other may equilibrate via transient bridged 
intermediates that facilitate overall atropisomerization (e.g. 
hydroxy- and formyl-groups, Scheme 1).[9] Diminished 
configurational stability hence manifests bridged intermediates 
with a higher ground state energy or reduced steric repulsion 
during rotation. Consequently, reactive groups need to be 
carefully selected or avoided in the reaction design and handling 
of atropisomers since even tetra-ortho-substituted biaryls may 
atropisomerize at relevant temperatures as a result of 
intramolecular reactivity.[10]  
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Scheme 1. Atropisomerization through the formation of a biaryl lactol bridge 
with a lower rotational barrier. 
In the case of nonbiaryl atropisomers, reactive groups are 
often already contained in the molecular backbone. For instance 
in axially chiral aromatic amides, a significant difference of the 
half-life of racemization at ambient temperature was observed 
by altering the reactivity of the ortho-substituents (Figure 3).[11] 
Specifically, converting the hydroxymethyl-group into a 
carbaldehyde leads to a substantial decrease of the 
configurational stability, presumably due to atropisomerization 
processes via bridged intermediates.[11b] Conclusively, steric 
repulsion and the reactivity of ortho- with the amide-substituents 
play a decisive role for the stereochemical integrity of aromatic 
amides. 
 
 
 
 
 
Figure 3. Estimated half-life of racemization of hydroxymethyl- and formyl- 
naphthamides at 20°C.[11b] 
Similarly, bimolecular equilibria to short-lived intermediates 
with lower rotational barriers provide a means for chemically 
induced atropisomerization processes. For instance BINOL, 
which is highly configurationally stable under neutral conditions, 
racemizes under strong acidic conditions.[12] Furthermore, 
photochemically induced transient intermediates have been 
reported as atropisomerization mechanism representatively for 
larger aromatic hydrocarbons.[13]  
Taking into account the different atropisomerization 
mechanisms, novel axially chiral compounds with unique 
molecular topology are expected to become available by 
exploring new concepts for their synthesis, for example by 
emulating biosynthetic reactivity principles. 
Biosynthesis of Aromatic Polyketides 
In pioneering studies, Collie discovered that diacetylacetone is 
converted to the aromatic compound orcinol by an arene-
forming aldol condensation in presence of sodium hydroxide 
(Scheme 2);[14] an observation on which he based his farsighted 
proposal that poly-β-ketones are key precursors in the 
biosynthesis of aromatic polyketides. This biogenic hypothesis 
was further substantiated by Robinson, Birch, Maitland, Harris 
and others,[15] and subsequently utilized for several elegant 
biomimetic syntheses of aromatic compounds.[16]  
 
 
 
Scheme 2. Collie’s synthesis of orcinol from diacetylacetone. 
In the biosynthesis of aromatic polyketide natural products, a 
captivating polyketide synthase (PKS) machinery first assembles 
poly-β-ketones to a defined length. The reactive poly-β-carbonyl 
chains are then folded into a PKS reaction channel to define the 
cyclization mode by cyclase/aromatase proteins (CYC/ARO).[17] 
To illustrate the controlling factors of these PKS-cascades in the 
context of stereoselectivity, the recently reported atropisomeric 
natural product fasamycin C serves as a particularly suitable 
example. The tridecaketide chain is here folded to provide a 
putative key intermediate for a final arene-forming aldol 
condensation, thus resulting in the stereoselective formation of a 
rotationally restricted tetra-ortho-substituted aromatic polyketide 
(Scheme 3). Decarboxylation and methylation steps conclude 
the biosynthesis of the axially chiral tri-ortho-substituted biaryl 
natural product fasamycin C, which was confirmed to be 
enantioenriched.[18] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Putative biosynthesis of fasamycin C.[18]  
Stereoselective Arene-forming Aldol 
Condensation: Atropisomeric Biaryls 
By adapting the mechanistic blueprint of this fascinating 
biosynthetic machinery, we delineated the possibilities of 
stereoselective arene-forming aldol condensations as synthetic 
concept. The generic reaction manifold is thus juxtaposed to a 
prototypical arene-forming aldol condensation to the aromatic 
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polyketide orsellinic acid (Scheme 4). The versatility of aldol 
chemistry for stereoselective catalysis is evident from the many 
available activation modes. To enable operationally simple 
amine catalysis, the substrate ideally bears an aldehyde, which 
generates an activated enamine intermediate. The -keto group 
provides a means for the formation of a six-membered ring that 
results in arene-formation upon dehydration. The carbonyl 
moieties at the β- and δ-position, respectively their 
corresponding tautomeric enol form, are replaceable by different 
alkene or arene groups and allow substrate diversification. In 
order to create configurationally stable atropisomers upon arene 
formation, two different substituents are installed at the terminal 
position. By combining these considerations with a viable 
substrate synthesis, various atropisomeric scaffolds may be 
conveniently prepared in enantioenriched form by a catalytic 
stereoselective arene-forming aldol condensation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4. The generic reaction manifold of the stereoselective arene-forming 
aldol condensation compared to orsellinic acid biosynthesis. 
In order to validate this notion, prototypical biaryls with well-
known configurational stability were explored at the outset of our 
studies.[19] For product diversification and structurally well-
defined substrates, a (Z)-alkene and variable phenyl groups 
were selected to furnish particularly valuable naphthalene-2-
carbaldehydes. A 1-naphthyl group provides the required third 
ortho-substituent, thus giving unsymmetrical binaphthalene-2-
carbaldehyde products (Scheme 5).  
 
 
 
 
 
 
 
 
 
Scheme 5. Secondary amine catalyzed arene-forming aldol condensation 
furnishing axially chiral 1,1'-binaphthalenes. 
The substrates were readily accessible by the addition of a 
1,2-dibromobenzene-derived aryl magnesium species to 1-
naphthaldehyde followed by a Sonogashira cross-coupling with 
3-butyn-1-ol and a (Z)-selective semi-hydrogenation of the 
ensuing alkyne. The ketoaldehyde was subsequently obtained 
by double oxidation of the diol with Dess-Martin periodinane 
(Scheme 6).  
 
 
 
 
 
 
 
Scheme 6. Substrate synthesis. 
While addition of L-Proline was found to provide the desired 
1,1’-binaphthalene-2-carbaldehyde product with a promising 
88:12 atroposelectivity, an enantiomeric excess of 99:1 was 
achieved with 5 mol% of the (S)-pyrrolidinyl-tetrazole catalyst.[20] 
Larger secondary amine catalysts showed inferior reactivity in 
this reaction, presumably due to a structurally encumbered 
transition state at the aldol addition step. The scope of the 
reaction embraces substrates with various substituents at the 
interstitial and terminal aryl groups, with tetra-ortho-substituted 
biaryl products representing a current limitation of this reaction 
(Scheme 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 7. Scope of the stereoselective arene-forming aldol condensation for 
atropisomeric biaryls. 
These first results supported the notion that the 
atroposelective arene-forming aldol condensation is a practical 
method for the preparation of unsymmetrical 1,1’-binaphthalene-
2-carbaldehydes and that high yields and excellent 
enantioselectivities are feasible. Due to its flexibility and the mild 
reaction conditions, it is expected to be useful for a wide range 
of applications. 
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Axially Chiral Aromatic Amides 
To corroborate the generality of the stereoselective arene-
forming aldol condensation as synthetic concept, the preparation 
of axially chiral aromatic amides was studied.[21] Furthermore, as 
aromatic amides are a common motif in medicinal chemistry, an 
increasing awareness of atropisomerism has been established 
in drug discovery.[22] 
In accord with the generic substrate layout, a terminal amide 
group provides a highly reactive substrate, thus giving tertiary 
formyl-naphthamides. Additionally, the intramolecular reactivity 
that affects the configurational stability of the products is 
balanced by installing a peri-substituent (Scheme 8). 
 
 
 
 
 
 
 
 
Scheme 8. Arene-forming aldol condensation to form configurationally stable 
aromatic amides. 
The ortho-substituted arylglyoxylic amide substrates were 
synthesized from aromatic 2,3-furandiones by an initial lactone-
opening/triflation sequence. After a Sonogashira cross-coupling 
with 3-butyn-1-ol followed by a (Z)-selective semi-hydrogenation, 
the highly reactive -keto-amide substrates were accessible 
after in situ oxidation (Scheme 9). 
 
 
 
 
 
 
Scheme 9. Synthesis of the ortho-substituted arylglyoxylic amide substrates.  
Upon addition of the (S)-pyrrolidinyl-tetrazole catalyst, 
selective and full conversion of the substrate was observed in 
presence of KHCO3. Intriguingly, the desired aldol condensation 
product was obtained with a stereoselectivity of 99:1 in less than 
two hours at room temperature (Scheme 10). To extend the 
scope of the process, the resulting ortho-carbaldehyde was 
subsequently reduced with NaBH4 to form ortho-hydroxymethyl-
substituted aromatic amides with higher configurational stability. 
Using this reaction sequence, even primary-alkyl N-disubstituted 
aromatic amides and various peri-substituted naphthamides 
were accessible with excellent enantiopurity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10. Substrate scope of the arene-forming aldol condensation for 
axially chiral aromatic amides. 
The atroposelective synthesis of configurationally stable 
aromatic amides confirmed that the arene-forming aldol 
condensation is a valuable synthetic strategy which delivers 
different axially chiral compounds. Furthermore, the 
configurational stability of the isolated hydroxy arylamides 
underlines their use as valuable chiral scaffolds. 
Oligo-1,2-naphthylenes 
Ortho-phenylenes belong to a class of helically shaped oligo- 
and polymers utilized in various fields of research (Figure 4a).[23] 
While many current applications profit from the stereodynamic 
behavior of these compounds, configurationally stable 
analogues are of particular interest in order to place substituents 
into a defined spatial arrangement.[24] The stereodynamic 
behavior of ortho-phenylenes is explained by the  di-ortho-
substitution of the biaryl subunits, which only provides one large 
rotational barrier (Figure 4b). A third ortho-substituent that is 
contained in the oligo-1,2-naphthylene structure consequently 
hinders rotation in both directions. Due to the resulting high 
rotational barriers, a pronounced configurational stability for 
each stereogenic axis was expected (Figure 4c).[25]  
 
 
 
 
 
 
 
 
Figure 4. Stereodynamic ortho-phenylenes vs. configurationally stable oligo-
1,2-napthylenes featuring a third ortho-substituent in each biaryl subunit. 
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The arene-forming aldol condensation proved to be an ideal 
method for the stereoselective synthesis of oligo-1,2-
naphthylenes. An iterative building block addition/oxidation/ 
arene-forming aldol condensation sequence allows an efficient 
and stereoselective synthesis of oligo-1,2-naphthylenes. 
For a expedient assembly of the oligomer, an organometallic 
building block with an alkoxide group was used to circumvent 
protecting group manipulations (Scheme 11).[26]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 11. Strategy for the stereoselective synthesis of oligo-1,2-
naphthylenes by a building block addition, double oxidation, aldol 
condensation sequence. 
The substrate for the first aldol condensation was obtained by 
the addition of the building block to naphthyl-2-carbaldehyde, 
which serves as end-group for the oligomer with regular 1,2’-
connectivity. A double oxidation with 2-iodoxybenzoic acid (IBX) 
and a subsequent arene-forming aldol condensation provided 
the stereodynamic di-ortho-substituted binaphthalene. With the 
second building block addition, a precursor for the first 
enantioselective aldol condensation was obtained. 
The diol was oxidized with IBX and initial conditions using (S)-
pyrrolidinyl tetrazole as catalyst in CDCl3 provided small 
amounts of the desired ternaphthalene with a first 
enantioselectivity of 92:8. Furthermore with natural amino acids 
as catalysts, superior yields were obtained and L-isoleucine was 
identified as an ideal catalyst considering a combination of yield 
and selectivity (Scheme 12a). With the ternaphthalene in hand, 
a remarkably high rotational barrier of G±453 K = 154 kJmol-1 was 
determined.   
The quarternaphthalenes with a second configurationally 
stable stereogenic axis were particularly interesting, as the 
diastereoisomers possess distinct molecular topologies. The 
precursor for this final aldol condensation was prepared as 
described previously and the aldol condensation was performed 
under substrate stereocontrol using LDA to yield both 
diastereomers with a d.r. of 79:21 (Scheme 12b). After 
separation of the diastereoisomers, the configurational stability 
was confirmed by their individual analysis in which stereoisomer 
interconversion was never observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 12. Catalyst-controlled enantioselective and substrate-controlled 
diastereoselective arene-forming aldol condensation. 
Conclusions and Perspective 
The use of small-molecule catalysts to control atroposelectivity 
in arene-forming aldol condensation was found to be a viable 
concept for the synthesis of various rotationally restricted 
compounds. Presumably, a structurally encumbered transition 
state of the aldol addition step provides the remarkable levels of 
selectivity upon activation of the substrate with a chiral catalyst. 
With the recently reported natural product fasamycin C, the 
biomimetic nature of this strategy has been confirmed and the 
discovery of further interesting atropisomeric aromatic polyketide 
natural products of this type is anticipated.  
The variability of the substrate and the mild conditions of these 
reliable and operationally simple reactions allow the synthesis of 
a broad range of structurally distinct atropisomers. It is expected 
that this synthetic concept will be useful for the preparation of a 
diversity of structurally well-defined compounds with novel 
topologies for a broad range of future applications. 
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An arena for carbonyl compounds: Intrigued by the biosynthesis of aromatic 
polyketides, stereoselective arene-forming aldol condensation reactions were 
investigated to form configurationally stable binaphthalenes, axially chiral amides 
and oligo-1,2-naphthylenes. As this versatile strategy provides various rotationally 
restricted compounds with high enantioselectivity, it is expected to be of great use 
in many areas of application.  
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